Siobhan Sutcliffe, PhD, ScM, MHS
Professor of Surgery; Associate Professor of Obstetrics and Gynecology
ScM, Johns Hopkins School of Hygiene and Public Health, Baltimore, MD, (Infectious Disease Epidemiology), 2001
MHS, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, (Biostatistics), 2004
PhD, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (Infectious Disease Epidemiology), 2005
Post Doctoral Education
Post-doctoral fellowship, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (Cancer Epidemiology), 2005-7
Faculty, Master of Population Health Sciences (MPHS) Program
Dr. Sutcliffe’s research program integrates epidemiologic and clinical research methodology to understand the etiology, progression, and exacerbation of clinically significant health problems that impact survival and quality of life. The ultimate goal of her research is to characterize modifiable risk factors and develop novel primary and secondary prevention strategies.
Dr. Sutcliffe’s research focuses on clinical conditions related to the male and female genitourinary and reproductive tracts. Conditions of interest include prostate cancer, benign prostatic hyperplasia, interstitial cystitis/bladder pain syndrome (IC/BPS), chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), urinary incontinence, lower urinary tract symptoms (LUTS), and urinary tract and sexually transmitted infections.
With funding from the NIDDK and NCI, Dr. Sutcliffe leads investigations in a number of established, national cohort studies and research consortia, including the NIDDK-sponsored Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network and the Prevention of Lower Urinary Tract Symptoms (PLUS) Research Consortium. She also co-directs the NIDDK-sponsored T32 program in Clinical Outcomes Research Training in Women’s Health with a Focus on Female Lower Urinary Tract Disorders.
In addition to her independent research, Dr. Sutcliffe regularly teams with collaborators internal to Washington University and beyond to conduct diverse studies involving clinical outcomes, therapeutic and preventive clinical trials, mixed-methods studies, comparative effectiveness analyses, and translational and biomarker studies.
600 S. Taylor Avenue
2nd floor, Rm. 208S, Box 8100
St. Louis, MO 63110